Should all CAR-T therapy for acute lymphoblastic leukemia Be consolidated with allogeneic stem cell transplant?

Keyphrases

• Chimeric Antigen Receptor T Cells (CAR-T) 100%
• CAR T-cell Therapy 100%
• Risk Factors 100%
• Allogeneic Transplant 100%
• Acute Lymphoblastic Leukemia 100%
• Response Rate 100%
• Genetic Modification 100%
• Effective Therapy 100%
• Relapsed or Refractory Acute Myeloid Leukemia 100%
• Autologous T Cell 100%
• Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) 100%
• Patient's Will 100%
• CD19 100%
• Allogeneic Haemopoietic Stem Cell Transplant 100%
• Consolidative Therapy 100%

Medicine and Dentistry

• Acute Lymphoblastic Leukemia 100%
• Stem Cell Transplant 100%
• Chimeric Antigen Receptor T-Cell Therapy 100%
• T Cell 50%
• Transplantation 50%
• Hematopoietic Cell 50%
• Chimeric Antigen Receptor 50%

Immunology and Microbiology

• Stem Cell Transplant 100%
• Chimeric Antigen Receptor T-Cell Therapy 100%
• T Cell 50%
• Hematopoietic Cell 50%
• Chimeric Antigen Receptor 50%
• CD19 50%